Here are eight key notes from orthopedic and spine device companies in the past week.
Zimmer Biomet partnered with construction solutions company Profica.
John A. Hatheway, MD, of Spokane, Wash., enrolled the first patient in the clinical study to evaluate Medtronic's SynchroMed II Intrathecal drug delivery system for patients with primary back pain.
Gramercy Extremity Orthopedics received FDA 10(k) clearance for its bone fragment fixation system GEO Nitinol Staple System.
Bolder Surgical, formerly known as JustRight Surgical, received $27 million in financing.
Medtronic Chairman and CEO Omar Ishrak and Executive Vice President and CFO Karen Parkhill participated in a Q&A at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, Jan. 7 to 10.
Kyocera International will purchase the major assets of Renovis Surgical Technologies' operations related to its artificial joint and spine products.
Medicrea issued its 2018 fourth quarter and full-year financial results.
Centinel Spine completed initial cases with the newest system in its FLX Platform of 3D-printed all-titanium interbody devices.